申请人:Wakamoto Pharmaceutical Co., Ltd.
公开号:US05602161A1
公开(公告)日:1997-02-11
The tetrazolylphenyl pivalate of the the following general formula or a pharmaceutically acceptable salt thereof: ##STR1## wherein R.sup.1 and R.sup.2 each represents a hydrogen atom, a lower alkyl group or other substituents; an elastase-inhibitory composition, a composition for preventing and treating emphysema and a composition for preventing and treating endotoxin-induced lung disorders each comprising the foregoing tetrazolylphenyl pivalate derivative or a non-toxic or acid-addition salt thereof.
下列通式的四唑基苯基缩酸酯或其药学上可接受的盐:##STR1##其中,R1和R2分别代表氢原子、较低的烷基或其他取代基;一种弹性蛋白酶抑制剂组合物、一种预防和治疗肺气肿的组合物和一种预防和治疗内毒素诱导的肺部疾病的组合物,每种组合物均包含上述四唑基苯基缩酸酯衍生物或其非毒性或酸加成盐。